Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

US Patent 11732030 · Granted Aug 22, 2023

Estimated economic value: $115,236,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for making antibodies based on use of an expression-enh2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Anti-MSR1 antibodies and methods of use thereof2025
Anti-MSR1 antibodies and methods of use thereof2025
Anti-MSR1 antibodies and methods of use thereof2025
Mice that make VL binding proteins2025
Method for generating high affinity antibodies2025
Mouse model of DITRA disease and uses thereof2025
Methods for modifying a genome2025
Pixel with vertical transfer structure for dark current improvement, an image se2025